Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model
- 1 March 2003
- journal article
- research article
- Published by Biology Centre, AS CR in Folia Parasitologica
- Vol. 50 (1) , 19-22
- https://doi.org/10.14411/fp.2003.003
Abstract
Cryptosporidium parvum, Tyzzer, 1912 is identified as a common cause of diarrhoea in immunocompetent individuals. In immunocompromised, especially HIV-infected subjects, cryptosporidiosis causes severe chronic diarrhoea. In this study, nitazoxanide (NTZ) was compared for curative activity with sinefungin (SNF) and paromomycin (PRM) in immunosuppressed rats, a screening model for anticryptosporidial agents. NTZ at either 50 mg/kg/day, 100 mg/kg/day or 200 mg/kg/day resulted in seven days in a dose-dependent inhibition of oocyst shedding similar to that obtained with SNF (10 mg/kg/day) and PRM (100 mg/kg/day). Further discontinuation of SNF or PRM 100 mg/kg/day therapy resulted in early relapse of oocyst shedding which reached the pre-treatment levels in 2-4 days. In contrast, seven days after discontinuation of therapy, shedding inhibition was unchanged in NTZ-treated rats. Data prompt further assessment of the activity of NTZ on sequestered C. parvum.Keywords
This publication has 20 references indexed in Scilit:
- In Vitro and In Vivo Activities of Nitazoxanide against Clostridium difficileAntimicrobial Agents and Chemotherapy, 2000
- Successful Treatment with Nitazoxanide of Enterocytozoon bieneusi Microsporidiosis in a Patient with AIDSAntimicrobial Agents and Chemotherapy, 2000
- Biliary tract cryptosporidiosis in an immunosuppressed rat modelPublished by Elsevier ,1999
- A double-‘blind’ placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in aids patients in MexicoTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Nitazoxanide, a Potential Drug for Eradication of Helicobacter pylori with No Cross-Resistance to MetronidazoleAntimicrobial Agents and Chemotherapy, 1998
- Comparative Efficacy Evaluation of Dicationic Carbazole Compounds, Nitazoxanide, and Paromomycin against Cryptosporidium parvum Infections in a Neonatal Mouse ModelAntimicrobial Agents and Chemotherapy, 1998
- Successful treatment of human fascioliasis with nitazoxanidePublished by Oxford University Press (OUP) ,1998
- Efficacy of Nitazoxanide against Cryptosporidium parvum in Cell Culture and in Animal ModelsAntimicrobial Agents and Chemotherapy, 1998
- Evaluation of high-dose regimen of paromomycin against cryptosporidiosis in the dexamethasone-treated rat modelAntimicrobial Agents and Chemotherapy, 1995
- Assessment of Candidate Anticryptosporidial Agents in an Immunosuppressed Rat ModelThe Journal of Infectious Diseases, 1993